Search clinical trials for: Thymic humoral factor gamma 2

Total 3348 results

The University of Hong Kong
Queen Elizabeth Hospital, Hong Kong; Queen Mary Hospital, Hong Kong; Pamela Youde... and other collaborators

Completed

H-IVIG Treatment for Severe H1N1 2009

Novel 2009 Influenza A (H1N1) Infection

Hong Kong
Abbott

Completed

Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.

Rheumatoid Arthritis

United States, Canada
M.D. Anderson Cancer Center
Bristol-Myers Squibb; National Cancer Institute (NCI); Iovance Biotherapeutics

Active, not recruiting

Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma

Malignant Solid Neoplasm | Metastatic Colorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Platinum-Resistant Ovarian Carcinoma | Metastatic Pancreatic Ductal Adenocarcinoma | Metastatic Ovarian Carcinoma and other conditions

United States
Kanecia Obie Zimmerman

Enrolling by invitation

RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG) (RECOVER-AUTO)

Long COVID | Long Covid-19 | Long Coronavirus Disease 2019 (Covid19)

United States
University of Oxford
University College London Hospitals; CSL Behring; Guy's and St Thomas' NHS Foundation... and other collaborators

Completed

Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis (IgNiTE)

Encephalitis

United Kingdom
George Sakoulas, MD
Octapharma

Completed

Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19

Sars-CoV2

United States
Sorlandet Hospital HF
Oslo University Hospital; University Hospital of North Norway; University Hospital...

Not yet recruiting

IVIG in Painful Sensory Neuropathy

Small Fiber Neuropathy | Sensory Neuropathy
Assiut University

Completed

IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients

Guillain-Barre Syndrome

Egypt
Vera Bril

Unknown

Panzyga in CIDP Administered at Different Infusion Rates (Panzyga-CIDP)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Canada
Oslo University Hospital
Helse Stavanger HF

Completed

Effect of Intravenous Immunglobulin (IVIG) After Myocardial Infarction

Acute Myocardial Infarction

Norway
Nabi Biopharmaceuticals

Completed

Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever

Staphylococcal Infections
M.D. Anderson Cancer Center

Completed

2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)

Leukemia

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

Breast Ductal Carcinoma In Situ

United States
Ontario Clinical Oncology Group (OCOG)
Canadian Breast Cancer Research Alliance; Ontario Cancer Research Network

Completed

Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1)

Metastatic Breast Cancer | Recurrent Breast Cancer

Canada
Sun Pharmaceutical Industries Limited

Completed

A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010) (reSURFACE 1)

Plaque Psoriasis
AbbVie

Completed

A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)

Psoriatic Arthritis
Emergent BioSolutions
Centers for Disease Control and Prevention

Enrolling by invitation

VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection

Complication of Smallpox Vaccination
Instituto Grifols, S.A.

Completed

Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)

COVID-19

Spain
Sandeep Jain, MD

Completed

IVIG-eye Drops Treatment for Dry Eye Disease

Dry Eye

United States
Laboratoire français de Fractionnement et de Biotechnologies
Parexel

Completed

Dose-finding Study of LFB-R593, A Monoclonal Anti-RhD Antibody, in Healthy RhD Negative Volunteers

Healthy

Germany
Assiut University

Unknown

Mini-pool Intravenous Immunoglobulin (MP-IVIG) in Guillain-Barré Syndrome

Guillain-Barre Syndrome
Peking Union Medical College Hospital
Tongji Hospital

Unknown

The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia

2019-nCoV
Cubist Pharmaceuticals LLC

Terminated

HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection

Liver Transplantation | Hepatitis B

New Zealand, United States, Israel, United Kingdom, France, Germany, Spain
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

Primary Immunodeficiency Diseases (PID)

Canada
Mayo Clinic
Grifols Biologicals, LLC

Withdrawn

Randomized Placebo Controlled Trial of IVIg in Glycine Receptor Antibody Positive Stiff-person Syndrome

Stiff-Person Syndrome

United States
University of Giessen
Hoffmann-La Roche; Astellas Pharma Inc; Heidelberg University; Aventis Pharmaceuticals

Completed

Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients

Renal Transplantation | Renal Failure, Chronic

Germany
Mayo Clinic
National Cancer Institute (NCI)

Completed

Aldesleukin Imaging in Viewing Tumor Growth in Patients With Stage IV Melanoma Receiving Ipilimumab or Pembrolizumab Therapy

Stage IV Skin Melanoma

United States
Children's Hospital Medical Center, Cincinnati
The Leona M. and Harry B. Helmsley Charitable Trust

Completed

Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION) (ENvISION)

Crohn's Disease | IBD

United States
Janssen Research & Development, LLC

Completed

A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis (VEGA)

Colitis, Ulcerative

United States, Russian Federation, Australia, Poland, Germany, Brazil, Ukraine, Argentina, Mexico
Biopharma Plasma LLC
Ivano-Frankivsk National Medical University; State Institution, Zaporizhzhia...

Recruiting

Human Anti-D (rh) Immunoglobulin (Rhesoglobin) Efficacy, Safety and Some Pharmacokinetics Parameters in Pregnant Women

Pregnancy Related

Ukraine
Grifols Therapeutics LLC

Completed

A Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Participants and Loading/Maintenance Dosing in Treatment-Naïve Participants With Primary Immunodeficiency

Primary Immunodeficiency

United States
Hoffmann-La Roche

Completed

A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation

Kidney Failure, Chronic

United States
CSL Behring

Completed

Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules

Primary Immune Deficiency | Secondary Immune Deficiency

Canada
Xinqiao Hospital of Chongqing
Peking University First Hospital; LanZhou University; RenJi Hospital; Qilu Hospital... and other collaborators

Unknown

Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women

Neonatal Alloimmune Thrombocytopenia
National Institute of Allergy and Infectious Diseases...

Completed

IVIG - West Nile Encephalitis: Safety and Efficacy

West Nile Virus

United States, Canada
Genzyme, a Sanofi Company

Completed

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients

Multiple Myeloma

United States, Canada, Germany
National Cancer Institute (NCI)

Terminated

Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma

Recurrent Neuroblastoma

United States
Fred Hutchinson Cancer Center
The Leukemia and Lymphoma Society; Juno Therapeutics, Inc., a Bristol-Myers...

Terminated

BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
Deepa Manwani

Recruiting

Intravenous Gammaglobulin for Sickle Cell Pain Crises

Pain | Sickle Cell Disease

United States
Johns Hopkins University

Terminated

Autoimmune Gastrointestinal Dysmotility: Symptoms, Pathogenesis and Treatment

Autoimmunity | Dysmotility Syndrome

United States
Baxalta now part of Shire

Completed

Gammagard Liquid and rHuPH20 in PID

Primary Immunodeficiency Diseases (PID)

United States, Canada
University of Pittsburgh
Bayer; Shadyside Hospital Foundation

Terminated

IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff

Clostridium Difficile-associated Diarrhea (CDAD)

United States
FFF Enterprises
OMRIX Biopharmaceuticals

Completed

A Clinical Study of Intravenous Immunoglobulin (IGIV)

Immunologic Deficiency Syndromes

United States, Canada
Biotest
Syneos Health

Completed

Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID

Primary Immunodeficiency Disease

United States, Germany, Hungary, Russian Federation, Spain
Baxalta now part of Shire

Completed

Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD

Primary Immunodeficiency Diseases (PID)

United States
Columbia University
Grifols Therapeutics LLC

Completed

Intravenous Immunoglobulin (IVIG) in Lung Transplantation

Lung Transplantation | Hypogammaglobulinemia

United States
Japan Blood Products Organization

Completed

Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM)

Dermatomyositis | Polymyositis

Japan
Camillo Ricordi and Jay Skyler
Diabetes Research Institute Foundation

Withdrawn

Diabetes Islet Preservation Immune Treatment (DIPIT)

Autoimmune Diseases | Diabetes Mellitus | Hypoglycemia | Diabetes Mellitus, Type 1

United States
Hookipa Biotech GmbH

Not yet recruiting

Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART

Human Immunodeficiency Virus (HIV) Infection

United States
Janssen Biotech, Inc.

Terminated

A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®) (REGAIN)

Arthritis, Rheumatoid

United States, Canada

Search clinical trials for: Thymic humoral factor gamma 2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations